Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Chris M. who wrote (3108)	6/2/1998 4:59:00 PM
From: Barron Von Hymen	Respond to of 9523

After watching the stock in all its weakness for the last few days, clearly, we see some heavy buying as soon as it hits 101 3/4 to 102. Since it tested 101 3/4 twice now with a strong rebound up to 113 and 105 3/4 respectively in the last week, I see around 102 as support level. But what's a couple bucks in the long run for the savvy investor, as over a year or so I can see this stock doubling. Aside from all the glamour and hype (both positive and negative) surrounding Viagra, remember that PFE is selling several other blockbuster drugs that have found their way in the shadows of Viagra's spotlight. My opinion is that PFE is bottoming out at the 102-103 level and is a bargain. Today, I loaded up on June 105 calls for 2 1/2. I can see it returning to 118 shortly.